Triclabendazole
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
Triclabendazole was approved in 2019 for treating fasciola in individuals ≥ 6 years.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
Triclabendazole was approved in 2019 for treating fasciola in individuals ≥ 6 years.
There's more to see -- the rest of this topic is available only to subscribers.